Fig. 3
From: CMTM3 suppresses chordoma progress through EGFR/STAT3 regulated EMT and TP53 signaling pathway
CMTM3 inhibited tumor growth in vivo. A total of 6 × 106 cells (U-CH1-MOCK or U-CH1-CMTM3) were inoculated into 5- to 6-week-old female NSG mice (n = 6 per group). A Images of tumor-bearing mice and B Visible tumors were obtained after the mice were sacrificed 5 months later. C The tumor volume of the mice was measured, calculated and shown in the bar graphs. D Tumor weight was measured and shown in the bar graphs